Estimating the state of the COVID-19 epidemic in France using a model with memory

This article has been Reviewed by the following groups

Read the full article

Abstract

In this paper, we use a deterministic epidemic model with memory to estimate the state of the COVID-19 epidemic in France, from early March until mid-December 2020. Our model is in the SEIR class, which means that when a susceptible individual (S) becomes infected, he/she is first exposed (E), i.e. not yet contagious. Then he/she becomes infectious (I) for a certain length of time, during which he/she may infect susceptible individuals around him/her, and finally becomes removed (R), that is, either immune or dead. The specificity of our model is that it assumes a very general probability distribution for the pair of exposed and infectious periods. The law of large numbers limit of such a model is a model with memory (the future evolution of the model depends not only upon its present state, but also upon its past). We present theoretical results linking the (unobserved) parameters of the model to various quantities which are more easily measured during the early stages of an epidemic. We then apply these results to estimate the state of the COVID-19 epidemic in France, using available information on the infection fatality ratio and on the distribution of the exposed and infectious periods. Using the hospital data published daily by Santé Publique France, we gather some information on the delay between infection and hospital admission, intensive care unit (ICU) admission and hospital deaths, and on the proportion of people who have been infected up to the end of 2020.

Article activity feed

  1. SciScore for 10.1101/2020.06.27.20141671: (What is this?)

    Please note, not all rigor criteria are appropriate for all manuscripts.

    Table 1: Rigor

    NIH rigor criteria are not applicable to paper type.

    Table 2: Resources

    No key resources detected.


    Results from OddPub: Thank you for sharing your code and data.


    Results from LimitationRecognizer: An explicit section about the limitations of the techniques employed in this study was not found. We encourage authors to address study limitations.

    Results from TrialIdentifier: No clinical trial numbers were referenced.


    Results from Barzooka: We did not find any issues relating to the usage of bar graphs.


    Results from JetFighter: We did not find any issues relating to colormaps.


    Results from rtransparent:
    • Thank you for including a conflict of interest statement. Authors are encouraged to include this statement when submitting to a journal.
    • Thank you for including a funding statement. Authors are encouraged to include this statement when submitting to a journal.
    • No protocol registration statement was detected.

    About SciScore

    SciScore is an automated tool that is designed to assist expert reviewers by finding and presenting formulaic information scattered throughout a paper in a standard, easy to digest format. SciScore checks for the presence and correctness of RRIDs (research resource identifiers), and for rigor criteria such as sex and investigator blinding. For details on the theoretical underpinning of rigor criteria and the tools shown here, including references cited, please follow this link.